losartan has been researched along with Obstructive Lung Diseases in 5 studies
Losartan: An antagonist of ANGIOTENSIN TYPE 1 RECEPTOR with antihypertensive activity due to the reduced pressor effect of ANGIOTENSIN II.
losartan : A biphenylyltetrazole where a 1,1'-biphenyl group is attached at the 5-position and has an additional trisubstituted imidazol-1-ylmethyl group at the 4'-position
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Butorov, IV | 1 |
| Verbitskiĭ, ON | 1 |
| Butorov, SI | 1 |
| Paraska, VI | 1 |
| Kiely, DG | 1 |
| Cargill, RI | 1 |
| Wheeldon, NM | 1 |
| Coutie, WJ | 1 |
| Lipworth, BJ | 1 |
| Morrell, NW | 1 |
| Vlahakos, DV | 1 |
| Marathias, KP | 1 |
| Kosmas, EN | 1 |
| Ogawa, M | 1 |
| Hirose, N | 1 |
| Ogimoto, M | 1 |
| Matsuki, H | 1 |
| Miki, K | 1 |
| Kinoshita, M | 1 |
| Koga, A | 1 |
| Saku, K | 1 |
1 trial available for losartan and Obstructive Lung Diseases
| Article | Year |
|---|---|
Haemodynamic and endocrine effects of type 1 angiotensin II receptor blockade in patients with hypoxaemic cor pulmonale.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Biphen | 1997 |
4 other studies available for losartan and Obstructive Lung Diseases
| Article | Year |
|---|---|
[Efficacy of losartan treatment of right ventricular cardiac insufficiency in patients with chronic obstructive bronchitis].
Topics: Adult; Angiotensin II; Bronchitis, Chronic; Drug Therapy, Combination; Hemodynamics; Humans; Losarta | 2003 |
Use of pulsed-wave Doppler echocardiography to measure changes in MPAP. Is further validation required?
Topics: Acute Disease; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhib | 1997 |
Losartan reduces hematocrit in patients with chronic obstructive pulmonary disease and secondary erythrocytosis.
Topics: Female; Hematocrit; Humans; Losartan; Lung Diseases, Obstructive; Male; Middle Aged; Polycythemia; R | 2001 |
Chronic beneficial effects of type 1 angiotensin II receptor antagonist in patients with chronic hypoxemic pulmonary diseases.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Natriuretic Factor; Female; Humans; Losartan | 2002 |